ArticleJournal of clinical immunology2023

BT595, a 10% Human Normal Immunoglobulin, for Replacement Therapy of Primary Immunodeficiency Disease: Results of a Subcohort Analysis in Children.

Gergely Kriván et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.